Dana-Farber, Mount Sinai study: Cancer clinical trials bounced back after significant COVID-19 disruption

J. Leonard Lichtenfeld joins SpotitEarly as CMO

J. Leonard Lichtenfeld joined SpotitEarly, an Israel-based technology company transforming cancer screening by harnessing the power of artificial intelligence and dogs to detect cancer early, as chief medical officer.

November 15, 2024

Vol.50 No.43

In Brief

Bertagnolli, Goldberg, Gunn, Brundage, and Theiler receive awards at Alliance fall meeting

NIH Director Monica M. Bertagnolli delivered the Charles G. Moertel Lecture at the Fall Group Meeting of the Alliance for Clinical Trials in Oncology. The meeting took place Oct. 30-Nov. 1.

November 15, 2024

Vol.50 No.43

Clinical Roundup

Phase I clinical trial of Keytruda + Lymphir for recurrent solid tumors yields positive preliminary results

Promising preliminary results from an ongoing investigator-initiated phase I clinical trial evaluating the safety and efficacy of a combined regimen of Keytrua (pembrolizumab) and Lymphir (denileukin diftitox-cxdl or E7777) in patients with recurrent solid tumors were announced.

November 15, 2024

Vol.50 No.43

Clinical Roundup

RAS-mutant leukemia stem cells behave differently from other leukemia stem cells

Research from the Icahn School of Medicine at Mount Sinai provides new insights into acute myeloid leukemia and its resistance to a common treatment. The study, published Oct. 30 in Nature, was led by Eirini Papapetrou, professor of oncological sciences at Icahn Mount Sinai. Acute myeloid leukemia is a devastating blood cancer that starts in...

November 08, 2024

Vol.50 No.42

In Brief

Mayo Clinic, IgniteData collaborate to deploy data transfer platform

IgniteData announced a collaboration with Mayo Clinic to deploy its Archer platform across multiple sites in the U.S., aiming to improve the management of clinical trial data by enhancing the transfer of information from Electronic Health Records to Electronic Data Capture systems.

October 25, 2024

Vol.50 No.40

In Brief

CEORT, Paradigm Health launch PACT Collective, expand clinical trial access and diversity

CEO Roundtable on Cancer and Paradigm Health Inc. announced a strategic partnership to launch the Partnership for Access, Collaboration, and Trust Collective. This pioneering initiative aims to break down barriers and create equitable access to oncology clinical trials, particularly for African American, Hispanic, and other underrepresented patient groups.

October 25, 2024

Vol.50 No.40

Dana-Farber, Mount Sinai study: Cancer clinical trials bounced back after significant COVID-19 disruption

YOU MAY BE INTERESTED IN

J. Leonard Lichtenfeld joins SpotitEarly as CMO

Bertagnolli, Goldberg, Gunn, Brundage, and Theiler receive awards at Alliance fall meeting

Phase I clinical trial of Keytruda + Lymphir for recurrent solid tumors yields positive preliminary results

RAS-mutant leukemia stem cells behave differently from other leukemia stem cells

Mayo Clinic, IgniteData collaborate to deploy data transfer platform

CEORT, Paradigm Health launch PACT Collective, expand clinical trial access and diversity

Renew today!

Subscriber content

Never miss an issue!

Login